Freelymater International Health Management Group is a leading high-tech enterprise in biomedicine and health management. Leveraging a top-tier research collaboration network, it integrates cutting-edge theories and diverse resources, strategically focusing on core areas such as cellular therapy and regenerative medicine. The group is dedicated to advancing technology development, clinical translation, and application. Its affiliated “Australia-Macau-Zhuhai Research Institute-Fumei Joint Laboratory” and “Wu Zuze Cellular Medicine Research Center” operate as national GMP-standard laboratories, laying a solid foundation for scientific innovation and industrial upgrading, driving the health industry to new heights.